Vitamin D in inflammatory diseases

Frontiers in Physiology

Volumn 5 JUL, Issue , 2014, Pages

  Wöbke, Thea K ^a   Sorg, Bernd L ^a   Steinhilber, Dieter ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

Cyclooxygenase; Innate immune system; Interleukins; MKP1; NFAT; NF B; VDR

Indexed keywords

ARACHIDONATE 5 LIPOXYGENASE; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN SYNTHASE; SMAD PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VITAMIN D;

ADIPOCYTE; ASTHMA; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CHROMATIN IMMUNOPRECIPITATION; CYTOKINE GENE; DENDRITIC CELL; DISEASE ASSOCIATION; ENDOMETRIUM CELL; ENDOTHELIUM CELL; ENZYME ACTIVATION; FIBROBLAST; GENE; GENE CONTROL; GENE EXPRESSION; GENE SILENCING; GENE SYNTHESIS; GENE TARGETING; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; INFLAMMATORY BOWEL DISEASE; INFLAMMATORY DISEASE; INTERFERON GAMMA GENE; KERATINOCYTE; LEUKOCYTE; MACROPHAGE; MONOCYTE; MULTIPLE SCLEROSIS; NEUTROPHIL; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PROTEIN SECRETION; PROTEIN SYNTHESIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TROPHOBLAST; VDR GENE; VITAMIN BLOOD LEVEL;

EID: 84904314348     PISSN: None     EISSN: 1664042X     Source Type: Journal    
DOI: 10.3389/fphys.2014.00244     Document Type: Review

References (269)

1. Abe, J., Moriya, Y., Saito, M., Sugawara, Y., Suda, T., and Nishii, Y. (1986). Modulation of cell growth, differentiation, and production of interleukin-3 by 1 alpha,25-dihydroxyvitamin D3 in the murine myelomonocytic leukemia cell line WEHI-3. Cancer Res. 46, 6316-6321.
2. Adorini, L., and Penna, G. (2008). Control of autoimmune diseases by the vitamin D endocrine system. Nat. Clin. Pract. Rheumatol. 4, 404-412. doi: 10.1038/ncprheum0855.
3. Alroy, I., Towers, T. L., and Freedman, L. P. (1995). Transcriptional repression of the interleukin-2 gene by vitamin D3: direct inhibition of NFATp/AP-1 complex formation by a nuclear hormone receptor. Mol. Cell. Biol. 15, 5789-5799.
4. Ananthakrishnan, A. N. (2013). Environmental triggers for inflammatory bowel disease. Curr. Gastroenterol. Rep. 15, 302. doi: 10.1007/s11894-012-0302-4.
5. Barnes, P. J. (1998). Anti-inflammatory actions of glucocorticoids: molecular mechanisms. Clin. Sci. (Lond.) 94, 557-572.
6. Bartels, L. E., Jorgensen, S. P., Bendix, M., Hvas, C. L., Agnholt, J., Agger, R., et al. (2013). 25-Hydroxy vitamin D3 modulates dendritic cell phenotype and function in Crohn's disease. Inflammopharmacology 21, 177-186. doi: 10.1007/s10787-012-0168-y.
7. Barthel, R., and Goldfeld, A. E. (2003). T cell-specific expression of the human TNF-alpha gene involves a functional and highly conserved chromatin signature in intron 3. J. Immunol. 171, 3612-3619. doi: 10.4049/jimmunol.171.7.3612.
8. Bendix-Struve, M., Bartels, L. E., Agnholt, J., Dige, A., Jorgensen, S. P., and Dahlerup, J. F. (2010). Vitamin D3 treatment of Crohn's disease patients increases stimulated T cell IL-6 production and proliferation. Aliment. Pharmacol. Ther. 32, 1364-1372. doi: 10.1111/j.1365-2036.2010.04463.x.
9. Bener, A., Ehlayel, M. S., Tulic, M. K., and Hamid, Q. (2012). Vitamin D deficiency as a strong predictor of asthma in children. Int. Arch. Allergy Immunol. 157, 168-175. doi: 10.1159/000323941.
10. Bennett, C. F., Chiang, M. Y., Monia, B. P., and Crooke, S. T. (1993). Regulation of 5-lipoxygenase and 5-lipoxygenase-activating protein expression in HL-60 cells. Biochem. J. 289 (Pt. 1), 33-39.
11. Bermudez, L. E., Young, L. S., and Gupta, S. (1990). 1,25 Dihydroxyvitamin D3-dependent inhibition of growth or killing of Mycobacterium avium complex in human macrophages is mediated by TNF and GM-CSF. Cell. Immunol. 127, 432-441. doi: 10.1016/0008-8749(90)90144-G.
12. Bhalla, A. K., Amento, E. P., and Krane, S. M. (1986). Differential effects of 1,25-dihydroxyvitamin D3 on human lymphocytes and monocyte/macrophages: inhibition of interleukin-2 and augmentation of interleukin-1 production. Cell. Immunol. 98, 311-322. doi: 10.1016/0008-8749(86)90291-1.
13. Bhalla, A. K., Paavonen, T., Williams, M. M., Delves, P. J., and Lydyard, P. M. (1991). Regulation of interleukin-1 and tumour necrosis factor gene expression in myelomonocytic cell lines by 1,25-dihydroxyvitamin D3. Immunology 72, 61-64.
14. Bierie, B., and Moses, H. L. (2010). Transforming growth factor beta (TGF-beta) and inflammation in cancer. Cytokine Growth Factor Rev. 21, 49-59. doi: 10.1016/j.cytogfr.2009.11.008.
15. Blifeld, C., Prehn, J. L., and Jordan, S. C. (1991). Stimulus-specific 1,25(OH)2D3 modulation of TNF and IL-1-beta gene expression in human peripheral blood mononuclear cells and monocytoid cell lines. Transplantation 51, 498-503. doi: 10.1097/00007890-199102000-00043.
16. Brehm, J. M., Acosta-Perez, E., Klei, L., Roeder, K., Barmada, M., Boutaoui, N., et al. (2012). Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am. J. Respir. Crit. Care Med. 186, 140-146. doi: 10.1164/rccm.201203-0431OC.
17. Brehm, J. M., Celedon, J. C., Soto-Quiros, M. E., Avila, L., Hunninghake, G. M., Forno, E., et al. (2009). Serum vitamin D levels and markers of severity of childhood asthma in Costa Rica. Am. J. Respir. Crit. Care Med. 179, 765-771. doi: 10.1164/rccm.200808-1361OC.
18. Brehm, J. M., Schuemann, B., Fuhlbrigge, A. L., Hollis, B. W., Strunk, R. C., Zeiger, R. S., et al. (2010). Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study. J. Allergy Clin. Immunol. 126, 52-58. doi: 10.1016/j.jaci.2010.03.043.
19. Brewer, L. C., Michos, E. D., and Reis, J. P. (2011). Vitamin D in atherosclerosis, vascular disease, and endothelial function. Curr. Drug Targets 12, 54-60. doi: 10.2174/138945011793591617.
20. Bruce, D., Yu, S., Ooi, J. H., and Cantorna, M. T. (2011). Converging pathways lead to overproduction of IL-17 in the absence of vitamin D signaling. Int. Immunol. 23, 519-528. doi: 10.1093/intimm/dxr045.
21. Brungs, M., Radmark, O., Samuelsson, B., and Steinhilber, D. (1994). On the induction of 5-lipoxygenase expression and activity in HL-60 cells: effects of vitamin D3, retinoic acid, DMSO and TGF beta. Biochem. Biophys. Res. Commun. 205, 1572-1580. doi: 10.1006/bbrc.1994.2846.
22. Brungs, M., Radmark, O., Samuelsson, B., and Steinhilber, D. (1995). Sequential induction of 5-lipoxygenase gene expression and activity in Mono Mac 6 cells by transforming growth factor beta and 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U.S.A. 92, 107-111. doi: 10.1073/pnas.92.1.107.
23. Burton, J. M., Kimball, S., Vieth, R., Bar-Or, A., Dosch, H. M., Cheung, R., et al. (2010). A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 74, 1852-1859. doi: 10.1212/WNL.0b013e3181e1cec2.
24. Camargo, C. A. Jr., Ingham, T., Wickens, K., Thadhani, R., Silvers, K. M., Epton, M. J., et al. (2011). Cord-blood 25-hydroxyvitamin D levels and risk of respiratory infection, wheezing, and asthma. Pediatrics 127, e180-e187. doi: 10.1542/peds.2010-0442.
25. Camargo, C. A. Jr., Rifas-Shiman, S. L., Litonjua, A. A., Rich-Edwards, J. W., Weiss, S. T., Gold, D. R., et al. (2007). Maternal intake of vitamin D during pregnancy and risk of recurrent wheeze in children at 3 y of age. Am. J. Clin. Nutr. 85, 788-795.
26. Carraro, S., Giordano, G., Reniero, F., Carpi, D., Stocchero, M., Sterk, P. J., et al. (2013). Asthma severity in childhood and metabolomic profiling of breath condensate. Allergy 68, 110-117. doi: 10.1111/all.12063.
27. Carrelli, A. L., Walker, M. D., Lowe, H., McMahon, D. J., Rundek, T., Sacco, R. L., et al. (2011). Vitamin D deficiency is associated with subclinical carotid atherosclerosis: the Northern Manhattan study. Stroke 42, 2240-2245. doi: 10.1161/STROKEAHA.110.608539.
28. Chang, S. H., Chung, Y., and Dong, C. (2010). Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression. J. Biol. Chem. 285, 38751-38755. doi: 10.1074/jbc.C110.185777.
29. Chen, W., Rogatsky, I., and Garabedian, M. J. (2006). MED14 and MED1 differentially regulate target-specific gene activation by the glucocorticoid receptor. Mol. Endocrinol. 20, 560-572. doi: 10.1210/me.2005-0318.
30. Cheraghi, N., Dai, H., and Raghuveer, G. (2012). Vitamin D deficiency is associated with atherosclerosis-promoting risk factor clustering but not vascular damage in children. Med. Sci. Monit. 18, CR687-CR692. doi: 10.12659/MSM.883593.
31. Chinellato, I., Piazza, M., Sandri, M., Peroni, D. G., Cardinale, F., Piacentini, G. L., et al. (2011b). Serum vitamin D levels and exercise-induced bronchoconstriction in children with asthma. Eur. Respir. J. 37, 1366-1370. doi: 10.1183/09031936.00044710.
32. Chinellato, I., Piazza, M., Sandri, M., Peroni, D., Piacentini, G., and Boner, A. L. (2011a). Vitamin D serum levels and markers of asthma control in Italian children. J. Pediatr. 158, 437-441. doi: 10.1016/j.jpeds.2010.08.043.
33. Cipollone, F., and Fazia, M. L. (2006). COX-2 and atherosclerosis. J. Cardiovasc. Pharmacol. 47(Suppl. 1), S26-S36. doi: 10.1097/00005344-200605001-00006.
34. Cippitelli, M., and Santoni, A. (1998). Vitamin D3: a transcriptional modulator of the interferon-gamma gene. Eur. J. Immunol. 28, 3017-3030.
35. Cohen, M. L., Douvdevani, A., Chaimovitz, C., and Shany, S. (2001). Regulation of TNF-alpha by 1alpha,25-dihydroxyvitamin D3 in human macrophages from CAPD patients. Kidney Int. 59, 69-75. doi: 10.1046/j.1523-1755.2001.00467.x.
36. Cohen-Lahav, M., Shany, S., Tobvin, D., Chaimovitz, C., and Douvdevani, A. (2006). Vitamin D decreases NFkappaB activity by increasing IkappaBalpha levels. Nephrol. Dial. Transplant. 21, 889-897. doi: 10.1093/ndt/gfi254.
37. Colin, E. M., Asmawidjaja, P. S., Van Hamburg, J. P., Mus, A. M., Van Driel, M., Hazes, J. M., et al. (2010). 1,25-dihydroxyvitamin D3 modulates Th17 polarization and interleukin-22 expression by memory T cells from patients with early rheumatoid arthritis. Arthritis Rheum. 62, 132-142. doi: 10.1002/art.25043.
38. Correale, J., Ysrraelit, M. C., and Gaitan, M. I. (2009). Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 132, 1146-1160. doi: 10.1093/brain/awp033.
39. Correale, J., Ysrraelit, M. C., and Gaitan, M. I. (2010). Gender differences in 1,25 dihydroxyvitamin D3 immunomodulatory effects in multiple sclerosis patients and healthy subjects. J. Immunol. 185, 4948-4958. doi: 10.4049/jimmunol.1000588.
40. Crispin, J. C., Martinez, A., De Pablo, P., Velasquillo, C., and Alcocer-Varela, J. (1998). Participation of the CD69 antigen in the T-cell activation process of patients with systemic lupus erythematosus. Scand. J. Immunol. 48, 196-200. doi: 10.1046/j.1365-3083.1998.00366.x.
41. Cutolo, M. (1999). Macrophages as effectors of the immunoendocrinologic interactions in autoimmune rheumatic diseases. Ann. N.Y. Acad. Sci. 876, 32-41. discussion: 41-32.
42. Dallaporta, M., Pecchi, E., Thirion, S., Jean, A., and Troadec, J. D. (2010). Toward the management of inflammation: recent developments of mPGES-1 inhibitors. Recent Pat. CNS Drug Discov. 5, 70-80. doi: 10.2174/157488910789753549.
43. D'Ambrosio, D., Cippitelli, M., Cocciolo, M. G., Mazzeo, D., Di Lucia, P., Lang, R., et al. (1998). Inhibition of IL-12 production by 1,25-dihydroxyvitamin D3. Involvement of NF-kappaB downregulation in transcriptional repression of the p40 gene. J. Clin. Invest. 101, 252-262. doi: 10.1172/JCI1050.
44. Deckx, N., Lee, W. P., Berneman, Z. N., and Cools, N. (2013). Neuroendocrine Immunoregulation in Multiple Sclerosis. Clin. Dev. Immunol. 2013:705232. doi: 10.1155/2013/705232.
45. Devereux, G., Litonjua, A. A., Turner, S. W., Craig, L. C., McNeill, G., Martindale, S., et al. (2007). Maternal vitamin D intake during pregnancy and early childhood wheezing. Am. J. Clin. Nutr. 85, 853-859.
46. Diaz, L., Noyola-Martinez, N., Barrera, D., Hernandez, G., Avila, E., Halhali, A., et al. (2009). Calcitriol inhibits TNF-alpha-induced inflammatory cytokines in human trophoblasts. J. Reprod. Immunol. 81, 17-24. doi: 10.1016/j.jri.2009.02.005.
47. Dimeloe, S., Richards, D. F., Urry, Z. L., Gupta, A., Stratigou, V., Farooque, S., et al. (2012). 1alpha,25-dihydroxyvitamin D3 promotes CD200 expression by human peripheral and airway-resident T cells. Thorax 67, 574-581. doi: 10.1136/thoraxjnl-2011-200651.
48. Ding, N., Yu, R. T., Subramaniam, N., Sherman, M. H., Wilson, C., Rao, R., et al. (2013). A vitamin D receptor/SMAD genomic circuit gates hepatic fibrotic response. Cell 153, 601-613. doi: 10.1016/j.cell.2013.03.028.
49. Di Rosa, M., Malaguarnera, G., De Gregorio, C., Palumbo, M., Nunnari, G., and Malaguarnera, L. (2012). Immuno-modulatory effects of vitamin D3 in human monocyte and macrophages. Cell. Immunol. 280, 36-43. doi: 10.1016/j.cellimm.2012.10.009.
50. Dong, J. Y., Zhang, W. G., Chen, J. J., Zhang, Z. L., Han, S. F., and Qin, L. Q. (2013). Vitamin D intake and risk of type 1 diabetes: a meta-analysis of observational studies. Nutrients 5, 3551-3562. doi: 10.3390/nu5093551.
51. Duque, J., Fresno, M., and Iniguez, M. A. (2005). Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J. Biol. Chem. 280, 8686-8693. doi: 10.1074/jbc.M413076200.
52. Ehlayel, M. S., Bener, A., and Sabbah, A. (2011). Is high prevalence of vitamin D deficiency evidence for asthma and allergy risks? Eur. Ann. Allergy Clin. Immunol. 43, 81-88.
53. Eleftheriadis, T., Antoniadi, G., Liakopoulos, V., Kartsios, C., Stefanidis, I., and Galaktidou, G. (2010). Paricalcitol reduces basal and lipopolysaccharide-induced (LPS) TNF-alpha and IL-8 production by human peripheral blood mononuclear cells. Int. Urol. Nephrol. 42, 181-185. doi: 10.1007/s11255-009-9541-1.
54. El-Shehaby, A. M., El-Khatib, M. M., Marzouk, S., and Battah, A. A. (2013). Relationship of BsmI polymorphism of vitamin D receptor gene with left ventricular hypertrophy and atherosclerosis in hemodialysis patients. Scand. J. Clin. Lab. Invest. 73, 75-81. doi: 10.3109/00365513.2012.743163.
55. Equils, O., Naiki, Y., Shapiro, A. M., Michelsen, K., Lu, D., Adams, J., et al. (2006). 1,25-Dihydroxyvitamin D inhibits lipopolysaccharide-induced immune activation in human endothelial cells. Clin. Exp. Immunol. 143, 58-64. doi: 10.1111/j.1365-2249.2005.02961.x.
56. Erkkola, M., Kaila, M., Nwaru, B. I., Kronberg-Kippila, C., Ahonen, S., Nevalainen, J., et al. (2009). Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin. Exp. Allergy 39, 875-882. doi: 10.1111/j.1365-2222.2009.03234.x.
57. Fagan, D. L., Prehn, J. L., Adams, J. S., and Jordan, S. C. (1991). The human myelomonocytic cell line U-937 as a model for studying alterations in steroid-induced monokine gene expression: marked enhancement of lipopolysaccharide-stimulated interleukin-1 beta messenger RNA levels by 1,25-dihydroxyvitamin D3. Mol. Endocrinol. 5, 179-186. doi: 10.1210/mend-5-2-179.
58. Fahmi, H. (2004). mPGES-1 as a novel target for arthritis. Curr. Opin. Rheumatol. 16, 623-627. doi: 10.1097/01.bor.0000129664.81052.8e.
59. Fang, W. L., Gao, L. B., Liang, W. B., Xue, H., Bai, P., Lv, M. L., et al. (2009). Association analysis of vitamin D receptor gene polymorphisms in chinese population with asthma. Iran. J. Allergy Asthma Immunol. 8, 141-147.
60. Feng, X., Lv, C., Wang, F., Gan, K., Zhang, M., and Tan, W. (2013). Modulatory effect of 1,25-dihydroxyvitamin D 3 on IL1 beta -induced RANKL, OPG, TNF alpha, and IL-6 expression in human rheumatoid synoviocyte MH7A. Clin. Dev. Immunol. 2013:160123. doi: 10.1155/2013/160123.
61. Fernandez-Herrera, J., Fernandez-Ruiz, E., Lopez-Cabrera, M., Garcia-Diez, A., Sanchez-Madrid, F., and Gonzalez-Amaro, R. (1996). CD69 expression and tumour necrosis factor-alpha immunoreactivity in the inflammatory cell infiltrate of halo naevi. Br. J. Dermatol. 134, 388-393. doi: 10.1111/j.1365-2133.1996.tb16219.x.
62. Flanders, K. C. (2004). Smad3 as a mediator of the fibrotic response. Int. J. Exp. Pathol. 85, 47-64. doi: 10.1111/j.0959-9673.2004.00377.x.
63. Franchi, B., Piazza, M., Sandri, M., Mazzei, F., Maffeis, C., and Boner, A. L. (2013). Vitamin D at the onset of type 1 diabetes in Italian children. Eur. J. Pediatr. 173, 477-482. doi: 10.1007/s00431-013-2204-3.
64. Frankenberger, M., Pforte, A., Sternsdorf, T., Passlick, B., Baeuerle, P. A., and Ziegler-Heitbrock, H. W. (1994). Constitutive nuclear NF-kappa B in cells of the monocyte lineage. Biochem. J. 304(Pt 1), 87-94.
65. Freishtat, R. J., Iqbal, S. F., Pillai, D. K., Klein, C. J., Ryan, L. M., Benton, A. S., et al. (2010). High prevalence of vitamin D deficiency among inner-city African American youth with asthma in Washington, DC. J. Pediatr. 156, 948-952. doi: 10.1016/j.jpeds.2009.12.033.
66. Fukuoka, M., Ogino, Y., Sato, H., Ohta, T., and Komoriya, K. (1998). Regulation of RANTES and IL-8 production in normal human dermal fibroblasts by active vitamin D3 (tacalcitol). Br. J. Pharmacol. 124, 1433-1438. doi: 10.1038/sj.bjp.0701988.
67. Gale, C. R., Robinson, S. M., Harvey, N. C., Javaid, M. K., Jiang, B., Martyn, C. N., et al. (2008). Maternal vitamin D status during pregnancy and child outcomes. Eur. J. Clin. Nutr. 62, 68-77. doi: 10.1038/sj.ejcn.1602680.
68. Garg, M., Lubel, J. S., Sparrow, M. P., Holt, S. G., and Gibson, P. R. (2012). Review article: vitamin D and inflammatory bowel disease-established concepts and future directions. Aliment. Pharmacol. Ther. 36, 324-344. doi: 10.1111/j.1365-2036.2012.05181.x.
69. Gatenby, P., Lucas, R., and Swaminathan, A. (2013). Vitamin D deficiency and risk for rheumatic diseases: an update. Curr. Opin. Rheumatol. 25, 184-191. doi: 10.1097/BOR.0b013e32835cfc16.
70. Gergen, P. J., Teach, S. J., Mitchell, H. E., Freishtat, R. F., Calatroni, A., Matsui, E., et al. (2013). Lack of a relation between serum 25-hydroxyvitamin D concentrations and asthma in adolescents. Am. J. Clin. Nutr. 97, 1228-1234. doi: 10.3945/ajcn.112.046961.
71. Gessl, A., and Waldhausl, W. (1998). Elevated CD69 expression on naive peripheral blood T-cells in hyperthyroid Graves' disease and autoimmune thyroiditis: discordant effect of methimazole on HLA-DR and CD69. Clin. Immunol. Immunopathol. 87, 168-175. doi: 10.1006/clin.1998.4524.
72. Ginde, A. A., Mansbach, J. M., and Camargo, C. A. Jr. (2009). Vitamin D, respiratory infections, and asthma. Curr. Allergy Asthma Rep. 9, 81-87. doi: 10.1007/s11882-009-0012-7.
73. Goldberg, P., Fleming, M. C., and Picard, E. H. (1986). Multiple sclerosis: decreased relapse rate through dietary supplementation with calcium, magnesium and vitamin D. Med. Hypotheses 21, 193-200. doi: 10.1016/0306-9877(86)90010-1.
74. Goleva, E., Searing, D. A., Jackson, L. P., Richers, B. N., and Leung, D. Y. (2012). Steroid requirements and immune associations with vitamin D are stronger in children than adults with asthma. J. Allergy Clin. Immunol. 129, 1243-1251. doi: 10.1016/j.jaci.2012.01.044.
75. Golovko, O., Nazarova, N., and Tuohimaa, P. (2005). Vitamin D-induced up-regulation of tumour necrosis factor alpha (TNF-alpha) in prostate cancer cells. Life Sci. 77, 562-577. doi: 10.1016/j.lfs.2004.10.072.
76. Gorman, S., Tan, D. H., Lambert, M. J., Scott, N. M., Judge, M. A., and Hart, P. H. (2012). Vitamin D(3) deficiency enhances allergen-induced lymphocyte responses in a mouse model of allergic airway disease. Pediatr. Allergy Immunol. 23, 83-87. doi: 10.1111/j.1399-3038.2011.01146.x.
77. Gupta, A., Bush, A., Hawrylowicz, C., and Saglani, S. (2012a). Vitamin D and asthma in children. Paediatr. Respir. Rev. 13, 236-243. quiz 243. doi: 10.1016/j.prrv.2011.07.003.
78. Gupta, A., Dimeloe, S., Richards, D. F., Bush, A., Saglani, S., and Hawrylowicz, C. M. (2012b). Vitamin D binding protein and asthma severity in children. J. Allergy Clin. Immunol. 129, 1669-1671. doi: 10.1016/j.jaci.2012.02.017.
79. Gynther, P., Toropainen, S., Matilainen, J. M., Seuter, S., Carlberg, C., and Vaisanen, S. (2011). Mechanism of 1alpha,25-dihydroxyvitamin D(3)-dependent repression of interleukin-12B. Biochim. Biophys. Acta 1813, 810-818. doi: 10.1016/j.bbamcr.2011.01.037.
80. Haeggstrom, J. Z., and Funk, C. D. (2011). Lipoxygenase and leukotriene pathways: biochemistry, biology, and roles in disease. Chem. Rev. 111, 5866-5898. doi: 10.1021/cr200246d.
81. Hakim, I., and Bar-Shavit, Z. (2003). Modulation of TNF-alpha expression in bone marrow macrophages: involvement of vitamin D response element. J. Cell. Biochem. 88, 986-998. doi: 10.1002/jcb.10453.
82. Halder, S. K., Goodwin, J. S., and Al-Hendy, A. (2011). 1,25-Dihydroxyvitamin D3 reduces TGF-beta3-induced fibrosis-related gene expression in human uterine leiomyoma cells. J. Clin. Endocrinol. Metab. 96, E754-E762. doi: 10.1210/jc.2010-2131.
83. Han, S. H., Jeon, J. H., Ju, H. R., Jung, U., Kim, K. Y., Yoo, H. S., et al. (2003). VDUP1 upregulated by TGF-beta1 and 1,25-dihydorxyvitamin D3 inhibits tumor cell growth by blocking cell-cycle progression. Oncogene 22, 4035-4046. doi: 10.1038/sj.onc.1206610.
84. Harant, H., Wolff, B., and Lindley, I. J. (1998). 1Alpha,25-dihydroxyvitamin D3 decreases DNA binding of nuclear factor-kappaB in human fibroblasts. FEBS Lett. 436, 329-334. doi: 10.1016/S0014-5793(98)01153-3.
85. Harizi, H., Corcuff, J. B., and Gualde, N. (2008). Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 14, 461-469. doi: 10.1016/j.molmed.2008.08.005.
86. Harle, D., Radmark, O., Samuelsson, B., and Steinhilber, D. (1998). Calcitriol and transforming growth factor-beta upregulate 5-lipoxygenase mRNA expression by increasing gene transcription and mRNA maturation. Eur. J. Biochem. 254, 275-281. doi: 10.1046/j.1432-1327.1998.2540275.x.
87. Heikkinen, S., Vaisanen, S., Pehkonen, P., Seuter, S., Benes, V., and Carlberg, C. (2011). Nuclear hormone 1alpha,25-dihydroxyvitamin D3 elicits a genome-wide shift in the locations of VDR chromatin occupancy. Nucleic Acids Res. 39, 9181-9193. doi: 10.1093/nar/gkr654.
88. Heine, G., Niesner, U., Chang, H. D., Steinmeyer, A., Zugel, U., Zuberbier, T., et al. (2008). 1,25-dihydroxyvitamin D(3) promotes IL-10 production in human B cells. Eur. J. Immunol. 38, 2210-2218. doi: 10.1002/eji.200838216.
89. Hidaka, M., Wakabayashi, I., Takeda, Y., and Fukuzawa, K. (2013). Vitamin D(3) derivatives increase soluble CD14 release through ERK1/2 activation and decrease IL-8 production in intestinal epithelial cells. Eur. J. Pharmacol. 721, 305-312. doi: 10.1016/j.ejphar.2013.09.014.
90. Higashimoto, Y., Ohata, M., Iwamoto, Y., Fujimoto, H., Uetani, K., Suruda, T., et al. (1995). Stimulatory effect of 1 alpha,25-dihydroxyvitamin D3 on mouse alveolar macrophage tumor necrosis factor-alpha production in vitro: involvement of protein kinase C and Ca2+/calmodulin-dependent kinase. Respiration 62, 89-94. doi: 10.1159/000196398.
91. Hodler, B., Evequoz, V., Trechsel, U., Fleisch, H., and Stadler, B. (1985). Influence of vitamin D3 metabolites on the production of interleukins 1,2 and 3. Immunobiology 170, 256-269. doi: 10.1016/S0171-2985(85)80075-9.
92. Hollams, E. M., Hart, P. H., Holt, B. J., Serralha, M., Parsons, F., De Klerk, N. H., et al. (2011). Vitamin D and atopy and asthma phenotypes in children: a longitudinal cohort study. Eur. Respir. J. 38, 1320-1327. doi: 10.1183/09031936.00029011.
93. Hullett, D. A., Laeseke, P. F., Malin, G., Nessel, R., Sollinger, H. W., and Becker, B. N. (2005). Prevention of chronic allograft nephropathy with vitamin D. Transpl. Int. 18, 1175-1186. doi: 10.1111/j.1432-2277.2005.00187.x.
94. Hypponen, E., Sovio, U., Wjst, M., Patel, S., Pekkanen, J., Hartikainen, A. L., et al. (2004). Infant vitamin d supplementation and allergic conditions in adulthood: northern Finland birth cohort 1966. Ann. N.Y. Acad. Sci. 1037, 84-95. doi: 10.1196/annals.1337.013.
95. Inoue, M., Matsui, T., Nishibu, A., Nihei, Y., Iwatsuki, K., and Kaneko, F. (1998). Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on inflammatory responses in psoriasis. Eur. J. Dermatol. 8, 16-20.
96. Ito, I., Waku, T., Aoki, M., Abe, R., Nagai, Y., Watanabe, T., et al. (2013). A nonclassical vitamin D receptor pathway suppresses renal fibrosis. J. Clin. Invest. 123, 4579-4594. doi: 10.1172/JCI67804.
97. Jain, S. K., and Micinski, D. (2013). Vitamin D upregulates glutamate cysteine ligase and glutathione reductase, and GSH formation, and decreases ROS and MCP-1 and IL-8 secretion in high-glucose exposed U937 monocytes. Biochem. Biophys. Res. Commun. 437, 7-11. doi: 10.1016/j.bbrc.2013.06.004.
98. Jamshidi, F., Zhang, J., Harrison, J. S., Wang, X., and Studzinski, G. P. (2008). Induction of differentiation of human leukemia cells by combinations of COX inhibitors and 1,25-dihydroxyvitamin D3 involves Raf1 but not Erk 1/2 signaling. Cell Cycle 7, 917-924. doi: 10.4161/cc.7.7.5620.
99. Jono, S., Nishizawa, Y., Shioi, A., and Morii, H. (1998). 1,25-Dihydroxyvitamin D3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 98, 1302-1306. doi: 10.1161/01.CIR.98.13.1302.
100. Jordan, S. C., Toyoda, M., Prehn, J., Lemire, J. M., Sakai, R., and Adams, J. S. (1989). 1,25-Dihydroxyvitamin-D3 regulation of interleukin-2 and interleukin-2 receptor levels and gene expression in human T cells. Mol. Immunol. 26, 979-984. doi: 10.1016/0161-5890(89)90116-8.
101. Joshi, S., Pantalena, L. C., Liu, X. K., Gaffen, S. L., Liu, H., Rohowsky-Kochan, C., et al. (2011). 1,25-dihydroxyvitamin D(3) ameliorates Th17 autoimmunity via transcriptional modulation of interleukin-17A. Mol. Cell. Biol. 31, 3653-3669. doi: 10.1128/MCB.05020-11.
102. Kankova, M., Luini, W., Pedrazzoni, M., Riganti, F., Sironi, M., Bottazzi, B., et al. (1991). Impairment of cytokine production in mice fed a vitamin D3-deficient diet. Immunology 73, 466-471.
103. Karin, M., and Lin, A. (2002). NF-kappaB at the crossroads of life and death. Nat. Immunol. 3, 221-227. doi: 10.1038/ni0302-221.
104. Kim, C. S., Joo, S. Y., Lee, K. E., Choi, J. S., Bae, E. H., Ma, S. K., et al. (2013). Paricalcitol attenuates 4-hydroxy-2-hexenal-induced inflammation and epithelial-mesenchymal transition in human renal proximal tubular epithelial cells. PLoS ONE 8:e63186. doi: 10.1371/journal.pone.0063186.
105. Kim, H. J., Abdelkader, N., Katz, M., and McLane, J. A. (1992). 1,25-Dihydroxy-vitamin-D3 enhances antiproliferative effect and transcription of TGF-beta1 on human keratinocytes in culture. J. Cell. Physiol. 151, 579-587. doi: 10.1002/jcp.1041510318.
106. Knip, M., and Simell, O. (2012). Environmental triggers of type 1 diabetes. Cold Spring Harb. Perspect. Med. 2:a007690. doi: 10.1101/cshperspect.a007690.
107. Koizumi, H., Kaplan, A., Shimizu, T., and Ohkawara, A. (1997). 1,25-Dihydroxyvitamin D3 and a new analogue, 22-oxacalcitriol, modulate proliferation and interleukin-8 secretion of normal human keratinocytes. J. Dermatol. Sci. 15, 207-213. doi: 10.1016/S0923-1811(97)00609-9.
108. Kong, J., Grando, S. A., and Li, Y. C. (2006). Regulation of IL-1 family cytokines IL-1alpha, IL-1 receptor antagonist, and IL-18 by 1,25-dihydroxyvitamin D3 in primary keratinocytes. J. Immunol. 176, 3780-3787. doi: 10.4049/jimmunol.176.6.3780.
109. Korf, H., Wenes, M., Stijlemans, B., Takiishi, T., Robert, S., Miani, M., et al. (2012). 1,25-Dihydroxyvitamin D3 curtails the inflammatory and T cell stimulatory capacity of macrophages through an IL-10-dependent mechanism. Immunobiology 217, 1292-1300. doi: 10.1016/j.imbio.2012.07.018.
110. Krobtrakulchai, W., Praikanahok, J., Visitsunthorn, N., Vichyanond, P., Manonukul, K., Pratumvinit, B., et al. (2013). The effect of vitamin d status on pediatric asthma at a university hospital, Thailand. Allergy Asthma Immunol. Res. 5, 289-294. doi: 10.4168/aair.2013.5.5.289.
111. Kudejko, J. (1968). Effect of vitamin D 3 and induced calciphylaxis on atherosclerosis of rabbits treated with cholesterol and calcium gluconate. Gerontologia 14, 35-44. doi: 10.1159/000211640.
112. Kudo, K., Hasegawa, S., Suzuki, Y., Hirano, R., Wakiguchi, H., Kittaka, S., et al. (2012). 1alpha,25-Dihydroxyvitamin D(3) inhibits vascular cellular adhesion molecule-1 expression and interleukin-8 production in human coronary arterial endothelial cells. J. Steroid Biochem. Mol. Biol. 132, 290-294. doi: 10.1016/j.jsbmb.2012.07.003.
113. Kull, I., Bergstrom, A., Melen, E., Lilja, G., Van Hage, M., Pershagen, G., et al. (2006). Early-life supplementation of vitamins A and D, in water-soluble form or in peanut oil, and allergic diseases during childhood. J. Allergy Clin. Immunol. 118, 1299-1304. doi: 10.1016/j.jaci.2006.08.022.
114. Kunitomo, M., Kinoshita, K., and Bando, Y. (1981). Experimental atherosclerosis in rats fed a vitamin D, cholesterol-rich diet. J. Pharmacobiodyn. 4, 718-723. doi: 10.1248/bpb1978.4.718.
115. Kuo, Y. T., Kuo, C. H., Lam, K. P., Chu, Y. T., Wang, W. L., Huang, C. H., et al. (2010). Effects of vitamin D3 on expression of tumor necrosis factor-alpha and chemokines by monocytes. J. Food Sci. 75, H200-H204. doi: 10.1111/j.1750-3841.2010.01704.x.
116. Lacey, D. L., Erdmann, J. M., and Tan, H. L. (1993a). 1,25-Dihydroxyvitamin D3 increases type 1 interleukin-1 receptor expression in a murine T cell line. J. Cell. Biochem. 52, 159-170. doi: 10.1002/jcb.240520208.
117. Lacey, D. L., Erdmann, J. M., Tan, H. L., and Ohara, J. (1993b). Murine osteoblast interleukin 4 receptor expression: upregulation by 1,25 dihydroxyvitamin D3. J. Cell. Biochem. 53, 122-134. doi: 10.1002/jcb.240530205.
118. Lagishetty, V., Liu, N. Q., and Hewison, M. (2011). Vitamin D metabolism and innate immunity. Mol. Cell. Endocrinol. 347, 97-105. doi: 10.1016/j.mce.2011.04.015.
119. Lan, H. Y. (2011). Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int. J. Biol. Sci. 7, 1056-1067. doi: 10.7150/ijbs.7.1056.
120. Larsen, C. G., Kristensen, M., Paludan, K., Deleuran, B., Thomsen, M. K., Zachariae, C., et al. (1991). 1,25(OH)2-D3 is a potent regulator of interleukin-1 induced interleukin-8 expression and production. Biochem. Biophys. Res. Commun. 176, 1020-1026. doi: 10.1016/0006-291X(91)90384-J.
121. Lee, B. N., Kim, T. H., Jun, J. B., Yoo, D. H., Woo, J. H., Choi, S. J., et al. (2011). Upregulation of interleukin-1beta production by 1,25-dihydroxyvitamin D(3) in activated human macrophages. Mol. Biol. Rep. 38, 2193-2201. doi: 10.1007/s11033-010-0348-z.
122. Lee, S. B., and Kalluri, R. (2010). Mechanistic connection between inflammation and fibrosis. Kidney Int. Suppl. 78, S22-S26. doi: 10.1038/ki.2010.418.
123. Lemire, J. M., Archer, D. C., Beck, L., and Spiegelberg, H. L. (1995). Immunosuppressive actions of 1,25-dihydroxyvitamin D3: preferential inhibition of Th1 functions. J. Nutr. 125, 1704s-1708s.
124. Li, B., Baylink, D. J., Deb, C., Zannetti, C., Rajaallah, F., Xing, W., et al. (2013). 1,25-Dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS ONE 8:e58808. doi: 10.1371/journal.pone.0058808.
125. Li, F., Jiang, L., Willis-Owen, S. A., Zhang, Y., and Gao, J. (2011a). Vitamin D binding protein variants associate with asthma susceptibility in the Chinese Han population. BMC Med. Genet. 12:103. doi: 10.1186/1471-2350-12-103.
126. Li, F., Peng, M., Jiang, L., Sun, Q., Zhang, K., Lian, F., et al. (2011b). Vitamin D deficiency is associated with decreased lung function in Chinese adults with asthma. Respiration 81, 469-475. doi: 10.1159/000322008.
127. Li, M. O., and Flavell, R. A. (2008). Contextual regulation of inflammation: a duet by transforming growth factor-beta and interleukin-10. Immunity 28, 468-476. doi: 10.1016/j.immuni.2008.03.003.
128. Li, Y. C., Kong, J., Wei, M., Chen, Z. F., Liu, S. Q., and Cao, L. P. (2002). 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J. Clin. Invest. 110, 229-238. doi: 10.1172/JCI0215219.
129. Liu, N. Q., Kaplan, A. T., Lagishetty, V., Ouyang, Y. B., Ouyang, Y., Simmons, C. F., et al. (2011). Vitamin D and the regulation of placental inflammation. J. Immunol. 186, 5968-5974. doi: 10.4049/jimmunol.1003332.
130. Liu, X., Nelson, A., Wang, X., Farid, M., Gunji, Y., Ikari, J., et al. (2014). Vitamin d modulates prostaglandin e2 synthesis and degradation in human lung fibroblasts. Am. J. Respir. Cell Mol. Biol. 50, 40-50. doi: 10.1165/rcmb.2013-0211OC.
131. Lyakh, L. A., Sanford, M., Chekol, S., Young, H. A., and Roberts, A. B. (2005). TGF-beta and vitamin D3 utilize distinct pathways to suppress IL-12 production and modulate rapid differentiation of human monocytes into CD83+ dendritic cells. J. Immunol. 174, 2061-2070. doi: 10.4049/jimmunol.174.4.2061.
132. Maalmi, H., Sassi, F. H., Berraies, A., Ammar, J., Hamzaoui, K., and Hamzaoui, A. (2013). Association of vitamin D receptor gene polymorphisms with susceptibility to asthma in Tunisian children: a case control study. Hum. Immunol. 74, 234-240. doi: 10.1016/j.humimm.2012.11.005.
133. Magnus, M. C., Stene, L. C., Haberg, S. E., Nafstad, P., Stigum, H., London, S. J., et al. (2013). Prospective study of maternal mid-pregnancy 25-hydroxyvitamin D Level and early childhood respiratory disorders. Paediatr. Perinat. Epidemiol. 27, 532-541. doi: 10.1111/ppe.12080.
134. Majak, P., Jerzynska, J., Smejda, K., Stelmach, I., Timler, D., and Stelmach, W. (2012). Correlation of vitamin D with Foxp3 induction and steroid-sparing effect of immunotherapy in asthmatic children. Ann. Allergy Asthma Immunol. 109, 329-335. doi: 10.1016/j.anai.2012.08.002.
135. Majak, P., Olszowiec-Chlebna, M., Smejda, K., and Stelmach, I. (2011). Vitamin D supplementation in children may prevent asthma exacerbation triggered by acute respiratory infection. J. Allergy Clin. Immunol. 127, 1294-1296. doi: 10.1016/j.jaci.2010.12.016.
136. Marcotorchino, J., Gouranton, E., Romier, B., Tourniaire, F., Astier, J., Malezet, C., et al. (2012). Vitamin D reduces the inflammatory response and restores glucose uptake in adipocytes. Mol. Nutr. Food Res. 56, 1771-1782. doi: 10.1002/mnfr.201200383.
137. Matilainen, J. M., Husso, T., Toropainen, S., Seuter, S., Turunen, M. P., Gynther, P., et al. (2010a). Primary effect of 1alpha,25(OH)(2)D(3) on IL-10 expression in monocytes is short-term down-regulation. Biochim. Biophys. Acta 1803, 1276-1286. doi: 10.1016/j.bbamcr.2010.07.009.
138. Matilainen, J. M., Rasanen, A., Gynther, P., and Vaisanen, S. (2010b). The genes encoding cytokines IL-2, IL-10 and IL-12B are primary 1alpha,25(OH)2D3 target genes. J. Steroid Biochem. Mol. Biol. 121, 142-145. doi: 10.1016/j.jsbmb.2010.03.020.
139. Matsui, T., Takahashi, R., Nakao, Y., Koizumi, T., Katakami, Y., Mihara, K., et al. (1986). 1,25-Dihydroxyvitamin D3-regulated expression of genes involved in human T-lymphocyte proliferation and differentiation. Cancer Res. 46, 5827-5831.
140. McNally, P., Coughlan, C., Bergsson, G., Doyle, M., Taggart, C., Adorini, L., et al. (2011). Vitamin D receptor agonists inhibit pro-inflammatory cytokine production from the respiratory epithelium in cystic fibrosis. J. Cyst. Fibros. 10, 428-434. doi: 10.1016/j.jcf.2011.06.013.
141. Menon, J., Maranda, L., and Nwosu, B. U. (2012). Serum 25-hydroxyvitamin D levels do not correlate with asthma severity in a case-controlled study of children and adolescents. J. Pediatr. Endocrinol. Metab. 25, 673-679. doi: 10.1515/jpem-2012-0143.
142. Meyer, M. B., Goetsch, P. D., and Pike, J. W. (2012). VDR/RXR and TCF4/beta-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression. Mol. Endocrinol. 26, 37-51. doi: 10.1210/me.2011-1109.
143. Miodovnik, M., Koren, R., Ziv, E., and Ravid, A. (2012). The inflammatory response of keratinocytes and its modulation by vitamin D: the role of MAPK signaling pathways. J. Cell. Physiol. 227, 2175-2183. doi: 10.1002/jcp.22951.
144. Mok, C. C., Birmingham, D. J., Leung, H. W., Hebert, L. A., Song, H., and Rovin, B. H. (2012). Vitamin D levels in Chinese patients with systemic lupus erythematosus: relationship with disease activity, vascular risk factors and atherosclerosis. Rheumatology (Oxf.) 51, 644-652. doi: 10.1093/rheumatology/ker212.
145. Moniaga, C. S., Egawa, G., Miyachi, Y., and Kabashima, K. (2013). Calcipotriol modulates IL-22 receptor expression and keratinocyte proliferation in IL-22-induced epidermal hyperplasia. J. Dermatol. Sci. 71, 76-77. doi: 10.1016/j.jdermsci.2013.03.011.
146. Moore, K. J., Sheedy, F. J., and Fisher, E. A. (2013). Macrophages in atherosclerosis: a dynamic balance. Nat. Rev. Immunol. 13, 709-721. doi: 10.1038/nri3520.
147. Morales, E., Romieu, I., Guerra, S., Ballester, F., Rebagliato, M., Vioque, J., et al. (2012). Maternal vitamin D status in pregnancy and risk of lower respiratory tract infections, wheezing, and asthma in offspring. Epidemiology 23, 64-71. doi: 10.1097/EDE.0b013e31823a44d3.
148. Moreno, J., Krishnan, A. V., Swami, S., Nonn, L., Peehl, D. M., and Feldman, D. (2005). Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells. Cancer Res. 65, 7917-7925. doi: 10.1158/0008-5472.can-05-1435.
149. Muller, K., and Bendtzen, K. (1992). Inhibition of human T lymphocyte proliferation and cytokine production by 1,25-dihydroxyvitamin D3. Differential effects on CD45RA+ and CD45R0+ cells. Autoimmunity 14, 37-43. doi: 10.3109/08916939309077355.
150. Muller, K., Haahr, P. M., Diamant, M., Rieneck, K., Kharazmi, A., and Bendtzen, K. (1992). 1,25-Dihydroxyvitamin D3 inhibits cytokine production by human blood monocytes at the post-transcriptional level. Cytokine 4, 506-512. doi: 10.1016/1043-4666(92)90012-G.
151. Muller, M. R., and Rao, A. (2010). NFAT, immunity and cancer: a transcription factor comes of age. Nat. Rev. Immunol. 10, 645-656. doi: 10.1038/nri2818.
152. Munger, K. L., Levin, L. I., Hollis, B. W., Howard, N. S., and Ascherio, A. (2006). Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA 296, 2832-2838. doi: 10.1001/jama.296.23.2832.
153. Munger, K. L., Zhang, S. M., O'Reilly, E., Hernan, M. A., Olek, M. J., Willett, W. C., et al. (2004). Vitamin D intake and incidence of multiple sclerosis. Neurology 62, 60-65. doi: 10.1212/01.WNL.0000101723.79681.38.
154. Murakami, M., Naraba, H., Tanioka, T., Semmyo, N., Nakatani, Y., Kojima, F., et al. (2000). Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J. Biol. Chem. 275, 32783-32792. doi: 10.1074/jbc.M003505200.
155. Mutt, S. J., Karhu, T., Lehtonen, S., Lehenkari, P., Carlberg, C., Saarnio, J., et al. (2012). Inhibition of cytokine secretion from adipocytes by 1,25-dihydroxyvitamin D(3) via the NF-kappaB pathway. FASEB J. 26, 4400-4407. doi: 10.1096/fj.12-210880.
156. Nakagawa, K., Sasaki, Y., Kato, S., Kubodera, N., and Okano, T. (2005). 22-Oxa-1alpha,25-dihydroxyvitamin D3 inhibits metastasis and angiogenesis in lung cancer. Carcinogenesis 26, 1044-1054. doi: 10.1093/carcin/bgi049.
157. Neve, A., Corrado, A., and Cantatore, F. P. (2013). Immunomodulatory effects of vitamin D in peripheral blood monocyte-derived macrophages from patients with rheumatoid arthritis. Clin. Exp. Med. doi: 10.1007/s10238-013-0249-2. [Epub ahead of print].
158. Nonn, L., Peng, L., Feldman, D., and Peehl, D. M. (2006). Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D. Cancer Res. 66, 4516-4524. doi: 10.1158/0008-5472.CAN-05-3796.
159. Oh, J., Riek, A. E., Weng, S., Petty, M., Kim, D., Colonna, M., et al. (2012). Endoplasmic reticulum stress controls M2 macrophage differentiation and foam cell formation. J. Biol. Chem. 287, 11629-11641. doi: 10.1074/jbc.M111.338673.
160. Ooi, J. H., Chen, J., and Cantorna, M. T. (2012). Vitamin D regulation of immune function in the gut: why do T cells have vitamin D receptors? Mol. Aspects Med. 33, 77-82. doi: 10.1016/j.mam.2011.10.014.
161. Ozgocmen, S., Bulut, S., Ilhan, N., Gulkesen, A., Ardicoglu, O., and Ozkan, Y. (2005). Vitamin D deficiency and reduced bone mineral density in multiple sclerosis: effect of ambulatory status and functional capacity. J. Bone Miner. Metab. 23, 309-313. doi: 10.1007/s00774-005-0604-9.
162. Panichi, V., De Pietro, S., Andreini, B., Bianchi, A. M., Migliori, M., Taccola, D., et al. (1998). Calcitriol modulates in vivo and in vitro cytokine production: a role for intracellular calcium. Kidney Int. 54, 1463-1469. doi: 10.1046/j.1523-1755.1998.00152.x.
163. Pedersen, A. W., Holmstrom, K., Jensen, S. S., Fuchs, D., Rasmussen, S., Kvistborg, P., et al. (2009). Phenotypic and functional markers for 1alpha,25-dihydroxyvitamin D(3)-modified regulatory dendritic cells. Clin. Exp. Immunol. 157, 48-59. doi: 10.1111/j.1365-2249.2009.03961.x.
164. Pedersen, L. B., Nashold, F. E., Spach, K. M., and Hayes, C. E. (2007). 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J. Neurosci. Res. 85, 2480-2490. doi: 10.1002/jnr.21382.
165. Penna, G., and Adorini, L. (2000). 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J. Immunol. 164, 2405-2411. doi: 10.4049/jimmunol.164.5.2405.
166. Penna, G., Fibbi, B., Amuchastegui, S., Corsiero, E., Laverny, G., Silvestrini, E., et al. (2009). The vitamin D receptor agonist elocalcitol inhibits IL-8-dependent benign prostatic hyperplasia stromal cell proliferation and inflammatory response by targeting the RhoA/Rho kinase and NF-kappaB pathways. Prostate 69, 480-493. doi: 10.1002/pros.20896.
167. Peric, M., Koglin, S., Kim, S. M., Morizane, S., Besch, R., Prinz, J. C., et al. (2008). IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes. J. Immunol. 181, 8504-8512. doi: 10.4049/jimmunol.181.12.8504.
168. Petrovic, N., Knight, D. A., Bomalaski, J. S., Thompson, P. J., and Misso, N. L. (2006). Concomitant activation of extracellular signal-regulated kinase and induction of COX-2 stimulates maximum prostaglandin E2 synthesis in human airway epithelial cells. Prostaglandins Other Lipid Mediat. 81, 126-135. doi: 10.1016/j.prostaglandins.2006.08.006.
169. Pike, K. C., Inskip, H. M., Robinson, S., Lucas, J. S., Cooper, C., Harvey, N. C., et al. (2012). Maternal late-pregnancy serum 25-hydroxyvitamin D in relation to childhood wheeze and atopic outcomes. Thorax 67, 950-956. doi: 10.1136/thoraxjnl-2012-201888.
170. Pillai, D. K., Iqbal, S. F., Benton, A. S., Lerner, J., Wiles, A., Foerster, M., et al. (2011). Associations between genetic variants in vitamin D metabolism and asthma characteristics in young African Americans: a pilot study. J. Investig. Med. 59, 938-946. doi: 10.231/JIM.0b013e318220df41.
171. Poon, A. H., Laprise, C., Lemire, M., Montpetit, A., Sinnett, D., Schurr, E., et al. (2004). Association of vitamin D receptor genetic variants with susceptibility to asthma and atopy. Am. J. Respir. Crit. Care Med. 170, 967-973. doi: 10.1164/rccm.200403-412OC.
172. Portales-Perez, D., Gonzalez-Amaro, R., Abud-Mendoza, C., and Sanchez-Armass, S. (1997). Abnormalities in CD69 expression, cytosolic pH and Ca2+ during activation of lymphocytes from patients with systemic lupus erythematosus. Lupus 6, 48-56. doi: 10.1177/096120339700600107.
173. Prabhu Anand, S., Selvaraj, P., and Narayanan, P. R. (2009). Effect of 1,25 dihydroxyvitamin D3 on intracellular IFN-gamma and TNF-alpha positive T cell subsets in pulmonary tuberculosis. Cytokine 45, 105-110. doi: 10.1016/j.cyto.2008.11.004.
174. Prehn, J. L., Fagan, D. L., Jordan, S. C., and Adams, J. S. (1992). Potentiation of lipopolysaccharide-induced tumor necrosis factor-alpha expression by 1,25-dihydroxyvitamin D3. Blood 80, 2811-2816.
175. Prehn, J. L., and Jordan, S. C. (1989). Incubation of T cell or monocytic cell lines with 1,25-dihydroxyvitamin D3 before mitogen stimulation potentiates IL-2 and IL-1 beta mRNA levels. Transplant. Proc. 21, 90-91.
176. Qin, X., Corriere, M. A., Matrisian, L. M., and Guzman, R. J. (2006). Matrix metalloproteinase inhibition attenuates aortic calcification. Arterioscler. Thromb. Vasc. Biol. 26, 1510-1516. doi: 10.1161/01.ATV.0000225807.76419.a7.
177. Raby, B. A., Lazarus, R., Silverman, E. K., Lake, S., Lange, C., Wjst, M., et al. (2004). Association of vitamin D receptor gene polymorphisms with childhood and adult asthma. Am. J. Respir. Crit. Care Med. 170, 1057-1065. doi: 10.1164/rccm.200404-447OC.
178. Rachez, C., Lemon, B. D., Suldan, Z., Bromleigh, V., Gamble, M., Naar, A. M., et al. (1999). Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 398, 824-828. doi: 10.1038/19783.
179. Ramagopalan, S. V., Heger, A., Berlanga, A. J., Maugeri, N. J., Lincoln, M. R., Burrell, A., et al. (2010). A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res. 20, 1352-1360. doi: 10.1101/gr.107920.110.
180. Ramalho, T. C., Rocha, M., Da Cunha, E. F., and Freitas, M. P. (2009). The search for new COX-2 inhibitors: a review of 2002 - 2008 patents. Expert Opin. Ther. Pat. 19, 1193-1228. doi: 10.1517/13543770903059125.
181. Rausch-Fan, X., Leutmezer, F., Willheim, M., Spittler, A., Bohle, B., Ebner, C., et al. (2002). Regulation of cytokine production in human peripheral blood mononuclear cells and allergen-specific th cell clones by 1alpha,25-dihydroxyvitamin D3. Int. Arch. Allergy Immunol. 128, 33-41. doi: 10.1159/000058001.
182. Reichel, H., Koeffler, H. P., Tobler, A., and Norman, A. W. (1987). 1 alpha,25-Dihydroxyvitamin D3 inhibits gamma-interferon synthesis by normal human peripheral blood lymphocytes. Proc. Natl. Acad. Sci. U.S.A. 84, 3385-3389. doi: 10.1073/pnas.84.10.3385.
183. Reis, J. P., Von Muhlen, D., Michos, E. D., Miller, E. R. 3rd, Appel, L. J., Araneta, M. R., et al. (2009). Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 207, 585-590. doi: 10.1016/j.atherosclerosis.2009.05.030.
184. Riancho, J. A., Zarrabeitia, M. T., De Francisco, A. L., Amado, J. A., Napal, J., Arias, M., et al. (1993). Vitamin D therapy modulates cytokine secretion in patients with renal failure. Nephron 65, 364-368. doi: 10.1159/000187514.
185. Richart, T., Li, Y., and Staessen, J. A. (2007). Renal versus extrarenal activation of vitamin D in relation to atherosclerosis, arterial stiffening, and hypertension. Am. J. Hypertens. 20, 1007-1015. doi: 10.1016/j.amjhyper.2007.03.017.
186. Riek, A. E., Oh, J., and Bernal-Mizrachi, C. (2013a). 1,25(OH)2 vitamin D suppresses macrophage migration and reverses atherogenic cholesterol metabolism in type 2 diabetic patients. J. Steroid Biochem. Mol. Biol. 136, 309-312. doi: 10.1016/j.jsbmb.2012.12.019.
187. Riek, A. E., Oh, J., Darwech, I., Moynihan, C. E., Bruchas, R. R., and Bernal-Mizrachi, C. (2013b). 25(OH) vitamin D suppresses macrophage adhesion and migration by downregulation of ER stress and scavenger receptor A1 in type 2 diabetes. J. Steroid Biochem. Mol. Biol. doi: 10.1016/j.jsbmb.2013.10.016. [Epub ahead of print].
188. Rigby, W. F., Denome, S., and Fanger, M. W. (1987). Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J. Clin. Invest. 79, 1659-1664. doi: 10.1172/JCI113004.
189. Rigby, W. F., Hamilton, B. J., and Waugh, M. G. (1990). 1,25-Dihydroxyvitamin D3 modulates the effects of interleukin 2 independent of IL-2 receptor binding. Cell. Immunol. 125, 396-414. doi: 10.1016/0008-8749(90)90094-8.
190. Rigby, W. F., Stacy, T., and Fanger, M. W. (1984). Inhibition of T lymphocyte mitogenesis by 1,25-dihydroxyvitamin D3 (calcitriol). J. Clin. Invest. 74, 1451-1455. doi: 10.1172/JCI111557.
191. Rostkowska-Nadolska, B., Sliupkas-Dyrda, E., Potyka, J., Kusmierz, D., Fraczek, M., Krecicki, T., et al. (2010). Vitamin D derivatives: calcitriol and tacalcitol inhibits interleukin-6 and interleukin-8 expression in human nasal polyp fibroblast cultures. Adv. Med. Sci. 55, 86-92. doi: 10.2478/v10039-010-0012-9.
192. Rothers, J., Wright, A. L., Stern, D. A., Halonen, M., and Camargo, C. A. Jr. (2011). Cord blood 25-hydroxyvitamin D levels are associated with aeroallergen sensitization in children from Tucson, Arizona. J. Allergy Clin. Immunol. 128, 1093.e5-1099.e5. doi: 10.1016/j.jaci.2011.07.015.
193. Ryynanen, J., and Carlberg, C. (2013). Primary 1,25-dihydroxyvitamin D3 response of the interleukin 8 gene cluster in human monocyte- and macrophage-like cells. PLoS ONE 8:e78170. doi: 10.1371/journal.pone.0078170.
194. Saadi, A., Gao, G., Li, H., Wei, C., Gong, Y., and Liu, Q. (2009). Association study between vitamin D receptor gene polymorphisms and asthma in the Chinese Han population: a case-control study. BMC Med. Genet. 10:71. doi: 10.1186/1471-2350-10-71.
195. Sachs, M. C., Brunzell, J. D., Cleary, P. A., Hoofnagle, A. N., Lachin, J. M., Molitch, M. E., et al. (2013). Circulating vitamin D metabolites and subclinical atherosclerosis in type 1 diabetes. Diabetes Care 36, 2423-2429. doi: 10.2337/dc12-2020.
196. Saggese, G., Federico, G., Balestri, M., and Toniolo, A. (1989). Calcitriol inhibits the PHA-induced production of IL-2 and IFN-gamma and the proliferation of human peripheral blood leukocytes while enhancing the surface expression of HLA class II molecules. J. Endocrinol. Invest. 12, 329-335. doi: 10.1007/BF03349999.
197. Schnatz, P. F., Nudy, M., O'Sullivan, D. M., Jiang, X., Cline, J. M., Kaplan, J. R., et al. (2012a). Coronary artery vitamin D receptor expression and plasma concentrations of 25-hydroxyvitamin D: their association with atherosclerosis. Menopause 19, 967-973. doi: 10.1097/gme.0b013e31824cfa8f.
198. Schnatz, P. F., Nudy, M., O'Sullivan, D. M., Jiang, X., Cline, J. M., Kaplan, J. R., et al. (2012b). The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas 73, 143-147. doi: 10.1016/j.maturitas.2012.03.014.
199. Schwalfenberg, G. K. (2011). A review of the critical role of vitamin D in the functioning of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 55, 96-108. doi: 10.1002/mnfr.201000174.
200. Searing, D. A., Zhang, Y., Murphy, J. R., Hauk, P. J., Goleva, E., and Leung, D. Y. (2010). Decreased serum vitamin D levels in children with asthma are associated with increased corticosteroid use. J. Allergy Clin. Immunol. 125, 995-1000. doi: 10.1016/j.jaci.2010.03.008.
201. Selvaraj, P., Vidyarani, M., Alagarasu, K., Prabhu Anand, S., and Narayanan, P. R. (2008). Regulatory role of promoter and 3' UTR variants of vitamin D receptor gene on cytokine response in pulmonary tuberculosis. J. Clin. Immunol. 28, 306-313. doi: 10.1007/s10875-007-9152-5.
202. Shanker, J., Maitra, A., Arvind, P., Nair, J., Dash, D., Manchiganti, R., et al. (2011). Role of vitamin D levels and vitamin D receptor polymorphisms in relation to coronary artery disease: the Indian atherosclerosis research study. Coron. Artery Dis. 22, 324-332. doi: 10.1097/MCA.0b013e3283472a57.
203. Shapira, Y., Agmon-Levin, N., and Shoenfeld, Y. (2010). Geoepidemiology of autoimmune rheumatic diseases. Nat. Rev. Rheumatol. 6, 468-476. doi: 10.1038/nrrheum.2010.86.
204. Sheppard, D. (2006). Transforming growth factor beta: a central modulator of pulmonary and airway inflammation and fibrosis. Proc. Am. Thorac. Soc. 3, 413-417. doi: 10.1513/pats.200601-008AW.
205. Sochorova, K., Budinsky, V., Rozkova, D., Tobiasova, Z., Dusilova-Sulkova, S., Spisek, R., et al. (2009). Paricalcitol (19-nor-1,25-dihydroxyvitamin D2) and calcitriol (1,25-dihydroxyvitamin D3) exert potent immunomodulatory effects on dendritic cells and inhibit induction of antigen-specific T cells. Clin. Immunol. 133, 69-77. doi: 10.1016/j.clim.2009.06.011.
206. Song, G. G., Bae, S. C., and Lee, Y. H. (2012). Association between vitamin D intake and the risk of rheumatoid arthritis: a meta-analysis. Clin. Rheumatol. 31, 1733-1739. doi: 10.1007/s10067-012-2080-7.
207. Sorg, B. L., Klan, N., Seuter, S., Dishart, D., Radmark, O., Habenicht, A., et al. (2006). Analysis of the 5-lipoxygenase promoter and characterization of a vitamin D receptor binding site. Biochim. Biophys. Acta 1761, 686-697. doi: 10.1016/j.bbalip.2006.04.005.
208. Spach, K. M., and Hayes, C. E. (2005). Vitamin D3 confers protection from autoimmune encephalomyelitis only in female mice. J. Immunol. 175, 4119-4126. doi: 10.4049/jimmunol.175.6.4119.
209. Srviastava, M. D., Deluca, H., and Ambrus, J. L. (1994). Inhibition of IL-6 and IL-8 production in human fibroblast cell lines by 1,25 (OH)2 vitamin D3 and two of its analogs with lower calcemic activity. Res. Commun. Chem. Pathol. Pharmacol. 83, 145-150.
210. Stan, D., Calin, M., Manduteanu, I., Pirvulescu, M., Gan, A. M., Butoi, E. D., et al. (2011). High glucose induces enhanced expression of resistin in human U937 monocyte-like cell line by MAPK- and NF-κB-dependent mechanisms; the modulating effect of insulin. Cell Tissue Res. 343, 379-387. doi: 10.1007/s00441-010-1092-3.
211. Stio, M., Martinesi, M., Bruni, S., Treves, C., Mathieu, C., Verstuyf, A., et al. (2007). The Vitamin D analogue TX 527 blocks NF-kappaB activation in peripheral blood mononuclear cells of patients with Crohn's disease. J. Steroid Biochem. Mol. Biol. 103, 51-60. doi: 10.1016/j.jsbmb.2006.07.008.
212. Stoffers, K. L., Sorg, B. L., Seuter, S., Rau, O., Radmark, O., and Steinhilber, D. (2010). Calcitriol upregulates open chromatin and elongation markers at functional vitamin D response elements in the distal part of the 5-lipoxygenase gene. J. Mol. Biol. 395, 884-896. doi: 10.1016/j.jmb.2009.10.022.
213. Stojanovic, O. I., Lazovic, M., Lazovic, M., and Vuceljic, M. (2011). Association between atherosclerosis and osteoporosis, the role of vitamin D. Arch. Med. Sci. 7, 179-188. doi: 10.5114/aoms.2011.22066.
214. Subramaniam, N., Leong, G. M., Cock, T. A., Flanagan, J. L., Fong, C., Eisman, J. A., et al. (2001). Cross-talk between 1,25-dihydroxyvitamin D3 and transforming growth factor-beta signaling requires binding of VDR and Smad3 proteins to their cognate DNA recognition elements. J. Biol. Chem. 276, 15741-15746. doi: 10.1074/jbc.M011033200.
215. Summerday, N. M., Brown, S. J., Allington, D. R., and Rivey, M. P. (2012). Vitamin D and multiple sclerosis: review of a possible association. J. Pharm. Pract. 25, 75-84. doi: 10.1177/0897190011421839.
216. Sun, J., Zhong, W., Gu, Y., Groome, L. J., and Wang, Y. (2013). 1,25(OH)D suppresses COX-2 up-regulation and thromboxane production in placental trophoblast cells in response to hypoxic stimulation. Placenta 35, 143-145. doi: 10.1016/j.placenta.2013.12.002.
217. Sun, X., and Zemel, M. B. (2008). Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J. Nutr. Biochem. 19, 392-399. doi: 10.1016/j.jnutbio.2007.05.013.
218. Sutherland, E. R., Goleva, E., Jackson, L. P., Stevens, A. D., and Leung, D. Y. (2010). Vitamin D levels, lung function, and steroid response in adult asthma. Am. J. Respir. Crit. Care Med. 181, 699-704. doi: 10.1164/rccm.200911-1710OC.
219. Szekely, J. I., and Pataki, A. (2012). Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review. Expert Rev. Respir. Med. 6, 683-704. doi: 10.1586/ers.12.57.
220. Szeto, F. L., Reardon, C. A., Yoon, D., Wang, Y., Wong, K. E., Chen, Y., et al. (2012). Vitamin D receptor signaling inhibits atherosclerosis in mice. Mol. Endocrinol. 26, 1091-1101. doi: 10.1210/me.2011-1329.
221. Tabata, T., Shoji, T., Kikunami, K., Matsushita, Y., Inoue, T., Tanaka, S., et al. (1988). In vivo effect of 1 alpha-hydroxyvitamin D3 on interleukin-2 production in hemodialysis patients. Nephron 50, 295-298. doi: 10.1159/000185191.
222. Taimi, M., Defacque, H., Commes, T., Favero, J., Caron, E., Marti, J., et al. (1993). Effect of retinoic acid and vitamin D on the expression of interleukin-1 beta, tumour necrosis factor-alpha and interleukin-6 in the human monocytic cell line U937. Immunology 79, 229-235.
223. Takahashi, K., Nakayama, Y., Horiuchi, H., Ohta, T., Komoriya, K., Ohmori, H., et al. (2002). Human neutrophils express messenger RNA of vitamin D receptor and respond to 1alpha,25-dihydroxyvitamin D3. Immunopharmacol. Immunotoxicol. 24, 335-347. doi: 10.1081/IPH-120014721.
224. Takeda, M., Yamashita, T., Sasaki, N., Nakajima, K., Kita, T., Shinohara, M., et al. (2010). Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions. Arterioscler. Thromb. Vasc. Biol. 30, 2495-2503. doi: 10.1161/ATVBAHA.110.215459.
225. Takeuchi, A., Reddy, G. S., Kobayashi, T., Okano, T., Park, J., and Sharma, S. (1998). Nuclear factor of activated T cells (NFAT) as a molecular target for 1alpha,25-dihydroxyvitamin D3-mediated effects. J. Immunol. 160, 209-218.
226. Talmor-Barkan, Y., Bernheim, J., Green, J., Benchetrit, S., and Rashid, G. (2011). Calcitriol counteracts endothelial cell pro-inflammatory processes in a chronic kidney disease-like environment. J. Steroid Biochem. Mol. Biol. 124, 19-24. doi: 10.1016/j.jsbmb.2011.01.001.
227. Taura, S., Taura, M., Kamio, A., and Kummerow, F. A. (1979). Vitamin D-induced coronary atherosclerosis in normolipemic swine: comparison with human disease. Tohoku J. Exp. Med. 129, 9-16. doi: 10.1620/tjem.129.9.
228. Tavakoli, M., Jeddi-Tehrani, M., Salek-Moghaddam, A., Rajaei, S., Mohammadzadeh, A., Sheikhhasani, S., et al. (2011). Effects of 1,25(OH)2 vitamin D3 on cytokine production by endometrial cells of women with recurrent spontaneous abortion. Fertil. Steril. 96, 751-757. doi: 10.1016/j.fertnstert.2011.06.075.
229. Thill, M., Becker, S., Fischer, D., Cordes, T., Hornemann, A., Diedrich, K., et al. (2009). Expression of prostaglandin metabolising enzymes COX-2 and 15-PGDH and VDR in human granulosa cells. Anticancer Res. 29, 3611-3618.
230. Thill, M., Fischer, D., Kelling, K., Hoellen, F., Dittmer, C., Hornemann, A., et al. (2010). Expression of vitamin D receptor (VDR), cyclooxygenase-2 (COX-2) and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) in benign and malignant ovarian tissue and 25-hydroxycholecalciferol (25(OH2)D3) and prostaglandin E2 (PGE2) serum level in ovarian cancer patients. J. Steroid Biochem. Mol. Biol. 121, 387-390. doi: 10.1016/j.jsbmb.2010.03.049.
231. Thill, M., Hoellen, F., Becker, S., Dittmer, C., Fischer, D., Kummel, S., et al. (2012). Expression of prostaglandin- and vitamin D-metabolising enzymes in benign and malignant breast cells. Anticancer Res. 32, 367-372.
232. Thota, C., Farmer, T., Garfield, R. E., Menon, R., and Al-Hendy, A. (2013). Vitamin D elicits anti-inflammatory response, inhibits contractile-associated proteins, and modulates Toll-like receptors in human myometrial cells. Reprod. Sci. 20, 463-475. doi: 10.1177/1933719112459225.
233. Toda, T., Ito, M., Toda, Y., Smith, T., and Kummerow, F. (1985). Angiotoxicity in swine of a moderate excess of dietary vitamin D3. Food Chem. Toxicol. 23, 585-592. doi: 10.1016/0278-6915(85)90183-8.
234. Toda, T., Leszczynski, D. E., and Kummerow, F. A. (1983). The role of 25-hydroxy-vitamin D3 in the induction of atherosclerosis in swine and rabbit by hypervitaminosis D. Acta Pathol. Jpn. 33, 37-44.
235. Tolppanen, A. M., Sayers, A., Granell, R., Fraser, W. D., Henderson, J., and Lawlor, D. A. (2013). Prospective association of 25-hydroxyvitamin d3 and d2 with childhood lung function, asthma, wheezing, and flexural dermatitis. Epidemiology 24, 310-319. doi: 10.1097/EDE.obo13e318280dd5e.
236. Tomasoni, S., Noris, M., Zappella, S., Gotti, E., Casiraghi, F., Bonazzola, S., et al. (1998). Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis. J. Am. Soc. Nephrol. 9, 1202-1212.
237. Tsatsanis, C., Androulidaki, A., Venihaki, M., and Margioris, A. N. (2006). Signalling networks regulating cyclooxygenase-2. Int. J. Biochem. Cell Biol. 38, 1654-1661. doi: 10.1016/j.biocel.2006.03.021.
238. Tsoukas, C. D., Provvedini, D. M., and Manolagas, S. C. (1984). 1,25-dihydroxyvitamin D3: a novel immunoregulatory hormone. Science 224, 1438-1440. doi: 10.1126/science.6427926.
239. Tsoukas, C. D., Watry, D., Escobar, S. S., Provvedini, D. M., Dinarello, C. A., Hustmyer, F. G., et al. (1989). Inhibition of interleukin-1 production by 1,25-dihydroxyvitamin D3. J. Clin. Endocrinol. Metab. 69, 127-133. doi: 10.1210/jcem-69-1-127.
240. Tuoresmäki, P., Vaisanen, S., Neme, A., Heikkinen, S., and Carlberg, C. (2014). Patterns of genome-wide VDR locations. PLoS ONE 9:e96105. doi: 10.1371/journal.pone.0096105.
241. Ueki, N., and Hayman, M. J. (2003). Signal-dependent N-CoR requirement for repression by the Ski oncoprotein. J. Biol. Chem. 278, 24858-24864. doi: 10.1074/jbc.M303447200.
242. Urry, Z., Chambers, E. S., Xystrakis, E., Dimeloe, S., Richards, D. F., Gabrysova, L., et al. (2012). The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur. J. Immunol. 42, 2697-2708. doi: 10.1002/eji.201242370.
243. Van Etten, E., Dardenne, O., Gysemans, C., Overbergh, L., and Mathieu, C. (2004). 1,25-Dihydroxyvitamin D3 alters the profile of bone marrow-derived dendritic cells of NOD mice. Ann. N.Y. Acad. Sci. 1037, 186-192. doi: 10.1196/annals.1337.030.
244. Van Etten, E., Verlinden, L., Giulietti, A., Ramos-Lopez, E., Branisteanu, D. D., Ferreira, G. B., et al. (2007). The vitamin D receptor gene FokI polymorphism: functional impact on the immune system. Eur. J. Immunol. 37, 395-405. doi: 10.1002/eji.200636043.
245. Van Oeffelen, A. A., Bekkers, M. B., Smit, H. A., Kerkhof, M., Koppelman, G. H., Haveman-Nies, A., et al. (2011). Serum micronutrient concentrations and childhood asthma: the PIAMA birth cohort study. Pediatr. Allergy Immunol. 22, 784-793. doi: 10.1111/j.1399-3038.2011.01190.x.
246. Verway, M., Bouttier, M., Wang, T. T., Carrier, M., Calderon, M., An, B. S., et al. (2013). Vitamin D induces interleukin-1beta expression: paracrine macrophage epithelial signaling controls M. tuberculosis infection. PLoS Pathog 9:e1003407. doi: 10.1371/journal.ppat.1003407.
247. Villaggio, B., Soldano, S., and Cutolo, M. (2012). 1,25-dihydroxyvitamin D3 downregulates aromatase expression and inflammatory cytokines in human macrophages. Clin. Exp. Rheumatol. 30, 934-938.
248. Vollmert, C., Illig, T., Altmuller, J., Klugbauer, S., Loesgen, S., Dumitrescu, L., et al. (2004). Single nucleotide polymorphism screening and association analysis-exclusion of integrin beta 7 and vitamin D receptor (chromosome 12q) as candidate genes for asthma. Clin. Exp. Allergy 34, 1841-1850. doi: 10.1111/j.1365-2222.2004.02047.x.
249. Wamberg, L., Cullberg, K. B., Rejnmark, L., Richelsen, B., and Pedersen, S. B. (2013). Investigations of the anti-inflammatory effects of vitamin D in adipose tissue: results from an in vitro study and a randomized controlled trial. Horm. Metab. Res. 45, 456-462. doi: 10.1055/s-0032-1331746.
250. Weng, S., Sprague, J. E., Oh, J., Riek, A. E., Chin, K., Garcia, M., et al. (2013). Vitamin D deficiency induces high blood pressure and accelerates atherosclerosis in mice. PLoS ONE 8:e54625. doi: 10.1371/journal.pone.0054625.
251. Willheim, M., Thien, R., Schrattbauer, K., Bajna, E., Holub, M., Gruber, R., et al. (1999). Regulatory effects of 1alpha,25-dihydroxyvitamin D3 on the cytokine production of human peripheral blood lymphocytes. J. Clin. Endocrinol. Metab. 84, 3739-3744.
252. Wingerchuk, D. M., Lesaux, J., Rice, G. P., Kremenchutzky, M., and Ebers, G. C. (2005). A pilot study of oral calcitriol (1,25-dihydroxyvitamin D3) for relapsing-remitting multiple sclerosis. J. Neurol. Neurosurg. Psychiatr. 76, 1294-1296. doi: 10.1136/jnnp.2004.056499.
253. Wobke, T. K., Von Knethen, A., Steinhilber, D., and Sorg, B. L. (2013). CD69 is a TGF-beta/1alpha,25-dihydroxyvitamin D3 target gene in monocytes. PLoS ONE 8, e64635. doi: 10.1371/journal.pone.0064635.
254. Wu, A. C., Tantisira, K., Li, L., Fuhlbrigge, A. L., Weiss, S. T., and Litonjua, A. (2012). Effect of vitamin D and inhaled corticosteroid treatment on lung function in children. Am. J. Respir. Crit. Care Med. 186, 508-513. doi: 10.1164/rccm.201202-0351OC.
255. Xiao, H. Q., Shi, W., Liu, S. X., Zhang, B., Xu, L. X., Liang, X. L., et al. (2009). Podocyte injury is suppressed by 1,25-dihydroxyvitamin D via modulation of transforming growth factor-beta 1/bone morphogenetic protein-7 signalling in puromycin aminonucleoside nephropathy rats. Clin. Exp. Pharmacol. Physiol. 36, 682-689. doi: 10.1111/j.1440-1681.2008.05133.x.
256. Yadav, A. K., Banerjee, D., Lal, A., and Jha, V. (2012). Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrology (Carlton) 17, 575-581. doi: 10.1111/j.1440-1797.2012.01611.x.
257. Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., et al. (1999). Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283, 1317-1321. doi: 10.1126/science.283.5406.1317.
258. Yang, J., Han, Y., Chen, C., Sun, H., He, D., Guo, J., et al. (2013). EGCG attenuates high glucose-induced endothelial cell inflammation by suppression of PKC and NF-kappaB signaling in human umbilical vein endothelial cells. Life Sci. 92, 589-597. doi: 10.1016/j.lfs.2013.01.025.
259. Yoon, J. W., and Jun, H. S. (1999). Cellular and molecular roles of beta cell autoantigens, macrophages and T cells in the pathogenesis of autoimmune diabetes. Arch. Pharm. Res. 22, 437-447. doi: 10.1007/BF02979150.
260. Yu, X. P., Bellido, T., and Manolagas, S. C. (1995). Down-regulation of NF-kappa B protein levels in activated human lymphocytes by 1,25-dihydroxyvitamin D3. Proc. Natl. Acad. Sci. U.S.A. 92, 10990-10994. doi: 10.1073/pnas.92.24.10990.
261. Yuan, L., Jiang, R., Yang, Y., Ding, S., and Deng, H. (2012). 1,25-Dihydroxyvitamin D3 inhibits growth of the breast cancer cell line MCF-7 and downregulates cytochrome P4501B1 through the COX-2/PGE2 pathway. Oncol. Rep. 28, 2131-2137. doi: 10.3892/or.2012.2031.
262. Zarrabeitia, M. T., Riancho, J. A., Amado, J. A., Olmos, J. M., and Gonzalez-Macias, J. (1992). Effect of calcitriol on the secretion of prostaglandin E2, interleukin 1, and tumor necrosis factor alpha by human monocytes. Bone 13, 185-189. doi: 10.1016/8756-3282(92)90010-T.
263. Zemplenyi, T., and Mrhova, O. (1965). Vascular enzyme activity changes accompanying the induction of experimental atherosclerosis. 2. Rats fed excess vitamin D. J. Atheroscler. Res. 5, 548-555. doi: 10.1016/S0368-1319(65)80031-X.
264. Zhang, H., Shih, D. Q., and Zhang, X. (2013a). Mechanisms underlying effects of 1,25-Dihydroxyvitamin D3 on the Th17 cells. Eur. J. Microbiol. Immunol. (Bp). 3, 237-240. doi: 10.1556/EuJMI.3.2013.4.1.
265. Zhang, J. Z., Maruyama, K., Ono, I., Iwatsuki, K., and Kaneko, F. (1994). Regulatory effects of 1,25-dihydroxyvitamin D3 and a novel vitamin D3 analogue MC903 on secretion of interleukin-1 alpha (IL-1 alpha) and IL-8 by normal human keratinocytes and a human squamous cell carcinoma cell line (HSC-1). J. Dermatol. Sci. 7, 24-31. doi: 10.1016/0923-1811(94)90018-3.
266. Zhang, Y., Leung, D. Y., and Goleva, E. (2013b). Vitamin D enhances glucocorticoid action in human monocytes: involvement of granulocyte-macrophage colony-stimulating factor and mediator complex subunit 14. J. Biol. Chem. 288, 14544-14553. doi: 10.1074/jbc.M112.427054.
267. Zhang, Y., Leung, D. Y., Richers, B. N., Liu, Y., Remigio, L. K., Riches, D. W., et al. (2012). Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J. Immunol. 188, 2127-2135. doi: 10.4049/jimmunol.1102412.
268. Zhou, C., Lu, F., Cao, K., Xu, D., Goltzman, D., and Miao, D. (2008). Calcium-independent and 1,25(OH)2D3-dependent regulation of the renin-angiotensin system in 1alpha-hydroxylase knockout mice. Kidney Int. 74, 170-179. doi: 10.1038/ki.2008.101.
269. Zipitis, C. S., and Akobeng, A. K. (2008). Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch. Dis. Child. 93, 512-517. doi: 10.1136/adc.2007.128579.